192 related articles for article (PubMed ID: 10454342)
1. Enhancing in vivo tumorigenicity of B16 melanoma by overexpressing interferon regulatory factor-2: resistance to endogenous IFN-gamma.
Yim JH; Wu SJ; Lowney JK; Vander Velde TL; Doherty GM
J Interferon Cytokine Res; 1999 Jul; 19(7):723-9. PubMed ID: 10454342
[TBL] [Abstract][Full Text] [Related]
2. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
[TBL] [Abstract][Full Text] [Related]
3. In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors.
Duguay D; Mercier F; Stagg J; Martineau D; Bramson J; Servant M; Lin R; Galipeau J; Hiscott J
Cancer Res; 2002 Sep; 62(18):5148-52. PubMed ID: 12234977
[TBL] [Abstract][Full Text] [Related]
4. The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines.
Yim JH; Ro SH; Lowney JK; Wu SJ; Connett J; Doherty GM
J Interferon Cytokine Res; 2003 Sep; 23(9):501-11. PubMed ID: 14565859
[TBL] [Abstract][Full Text] [Related]
5. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
[TBL] [Abstract][Full Text] [Related]
6. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
Böhm W; Thoma S; Leithäuser F; Möller P; Schirmbeck R; Reimann J
J Immunol; 1998 Jul; 161(2):897-908. PubMed ID: 9670968
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
8. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.
Rodrigues EG; Garofalo AS; Travassos LR
Cytokines Cell Mol Ther; 2002; 7(3):107-16. PubMed ID: 12850810
[TBL] [Abstract][Full Text] [Related]
9. Activation of IRF3 contributes to IFN-γ and ISG54 expression during the immune responses to B16F10 tumor growth.
Guinn Z; Brown DM; Petro TM
Int Immunopharmacol; 2017 Sep; 50():121-129. PubMed ID: 28651122
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
Nguyen H; Mustafa A; Hiscott J; Lin R
Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
[TBL] [Abstract][Full Text] [Related]
11. Localization of IFN-gamma-activated Stat1 and IFN regulatory factors 1 and 2 in breast cancer cells.
Connett JM; Hunt SR; Hickerson SM; Wu SJ; Doherty GM
J Interferon Cytokine Res; 2003 Nov; 23(11):621-30. PubMed ID: 14651776
[TBL] [Abstract][Full Text] [Related]
12. Regulation of interferon responses in medulloblastoma cells by interferon regulatory factor-1 and -2.
Park KC; Shimizu K; Hayakawa T; Tanaka N
Br J Cancer; 1998 Jun; 77(12):2081-7. PubMed ID: 9649118
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor-1 mediates interferon-gamma-induced apoptosis in ovarian carcinoma cells.
Kim EJ; Lee JM; Namkoong SE; Um SJ; Park JS
J Cell Biochem; 2002; 85(2):369-80. PubMed ID: 11948692
[TBL] [Abstract][Full Text] [Related]
14. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
Grieder FB; Vogel SN
Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925
[TBL] [Abstract][Full Text] [Related]
15. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo.
Hobart M; Ramassar V; Goes N; Urmson J; Halloran PF
J Immunol; 1997 May; 158(9):4260-9. PubMed ID: 9126988
[TBL] [Abstract][Full Text] [Related]
16. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
17. Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation.
Coccia EM; Stellacci E; Valtieri M; Masella B; Feccia T; Marziali G; Hiscott J; Testa U; Peschle C; Battistini A
Biochem J; 2001 Dec; 360(Pt 2):285-94. PubMed ID: 11716756
[TBL] [Abstract][Full Text] [Related]
18. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
19. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma signaling in human retinal pigment epithelial cells mediated by STAT1, ICSBP, and IRF-1 transcription factors.
Li W; Nagineni CN; Hooks JJ; Chepelinsky AB; Egwuagu CE
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):976-82. PubMed ID: 10102295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
